enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Haleon to recall batches of some adult cough syrups due to ...

   www.aol.com/news/haleon-recall-batches-adult...

   The consumer healthcare company is recalling the cough syrup, sold under the brand name "Robitussin Honey CF Max Day Adult" in 4-ounce and 8-ounce doses, along with its 8-ounce night-time version.

3. Robitussin cough syrup recall issued nationwide due to ... - AOL

   www.aol.com/robitussin-cough-syrup-recall-issued...

   Robitussin Honey CF Max Day and Nighttime are cough syrups indicted for the temporary relief of symptoms occurring with cold or flu, hay fever, or other respiratory allergies, according to Haleon.

4. Robitussin cough syrups are being recalled due to risk of ...

   www.aol.com/news/robitussin-cough-syrups-being...

   Robitussin cough syrup is being recalled due to microbial contamination that can lead to fungemia. Honey flavors are included in the 2024 recall.

5. Cold medicine - Wikipedia

   en.wikipedia.org/wiki/Cold_medicine

   A small study found honey may be a minimally effective cough treatment due to "well-established antioxidant and antimicrobial effects" and a tendency to soothe irritated tissue. [21] A Cochrane review found there was weak evidence to recommend for or against the use of honey in children as a cough remedy. [22]

6. Recreational use of dextromethorphan - Wikipedia

   en.wikipedia.org/wiki/Recreational_use_of_dext...

   Dextromethorphan, or DXM, a common active ingredient found in many over-the-counter cough suppressant cold medicines, is used as a recreational drug and entheogen for its dissociative effects. [1] Street names include Brownies , Dextro , Drix , Gel , Groove , Lean , Mega-perls , Poor man's ecstasy , Poor man's PCP, Red devils , Robo , Rojo ...

7. Dextromethorphan - Wikipedia

   en.wikipedia.org/wiki/Dextromethorphan

   Dextromethorphan (DXM), sold under the trade name Robitussin among others, is a cough suppressant used in many cough and cold medicines. [6] In 2022, the US Food and Drug Administration (FDA) approved the combination dextromethorphan/bupropion to serve as a rapid-acting antidepressant in patients with major depressive disorder .